治疗体质投诉患者和患有额外工作相关焦虑症患者的机会和挑战 - 一项混合方法研究
Lara Kleist1, Franziska Weißenstein1, Beate Muschalla2
1Center for Health Services Research, Brandenburg Medical School Theodor Fontane, Fehrbelliner Str. 38, 16816 Neuruppin, Germany.
International journal of environmental research and public health
|January 28, 2026
概括
在体力康复中,患有与工作有关的焦虑症的患者面临着未得到满足的心理需求和有限的支持. 有针对性的干预措施对于改善他们返回工作的结果和整体幸福感至关重要.
科学领域:
- 公共卫生 公共卫生
- 职业健康 职业健康 职业健康
- 康复医学 康复医学 康复医学
背景情况:
- 与工作相关的焦虑在体力康复中普遍存在,影响工作能力和返回工作的可能性.
- 从公共卫生角度来看,在这种环境中,患者对工作相关焦虑的经验的研究有限.
- 这项研究通过检查患有体质投诉和同时出现与工作有关的焦虑症的患者的护理来弥补这一差距.
研究的目的:
- 在康复中调查体质投诉和与工作有关的焦虑症患者的经验和支持需求.
- 确定高 (JA) 和低 (nJA) 职业焦虑患者之间的护理和结果差异.
- 为制定有针对性的干预措施提供信息,以改善返回工作的情况.
主要方法:
- 顺序混合方法方法使用半结构面试和问卷.
- 在2022年采访了18名骨科康复患者.
- 53名患者在2023年填写了问卷,并根据工作焦虑量表得分进行了定性分析.
主要成果:
- 患有高职业焦虑症 (JA) 的患者报告了未得到满足的心理需求,有限的以工作为中心的治疗,财务障碍和不充分的职业支持.
- 较低的工作焦虑 (nJA) 患者拥有更强大的社交网络,稳定的财务状况和更好的医疗保健服务.
- 两组都经历了混合的工作场所支持;JA患者特别需要与工作相关的干预措施.
结论:
- 在医疗保健,工作场所和康复方面,JA和nJA患者的经验,挑战和支持需求存在显著差异.
- 在康复机构内,JA患者需要量身定制,以工作为中心的干预措施.
- 这些试点发现需要进一步的研究来验证和扩展观察到的差异和需求.
更多相关视频
相关概念视频
01:13Patient-centered Care
3.0K
Patient-centered care involves delivering care beyond inpatient hospitalization. Reflective practice can enhance a patient-centered approach. Reflective practice is a process of reasoning that considers all aspects of the present situation, including practicalities, learning from personal practice, and consideration of patient needs. Patients appreciate care decisions made while considering their input. Involving the patient in their care provides the patient with a sense of contribution rather...
3.0K
01:15Bioavailability Study Design: Healthy Subjects Versus Patients
147
Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
147
01:15Drug Dosing: Geriatric Patients
232
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
232
01:21Drug Dosing: Obese Patients
254
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
254
01:27Pharmacodynamics in Geriatric Patients: Effects of Age
202
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
202
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
225
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
225